Inovio Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +43.0% | -18.0% | -42.2% | -18.3% | +199.5% | +29.1% | +38.3% | +24.1% | +10.6% | -2.0% | +106.8% | -30.5% | +9.0% | -26.1% | +95.6% | +49.3% | +62.3% | -18.8% | +7.8% | -30.0% | +9.8% | +275.0% | -8.1% | -29.7% | -51.0% | -33.8% | -34.4% | |
| – | +52.8% | -29.0% | -56.3% | -25.2% | +409.7% | +34.1% | -0.6% | +33.6% | +18.5% | -47.4% | +192.0% | -48.7% | +39.5% | -50.0% | +267.5% | +68.6% | +73.7% | -27.5% | +11.0% | -36.5% | +7.3% | +400.2% | -4.8% | -29.7% | -51.4% | -36.1% | -37.5% | |
| – | +57.1% | -61.8% | -51.3% | -51.7% | +1,437.6% | +32.9% | -4.0% | -51.5% | +23.2% | +37.7% | +114.6% | -34.0% | -13.2% | -67.5% | +497.2% | +20.2% | +42.1% | -66.8% | +24.3% | -0.4% | -6.3% | +1,029.6% | -71.6% | -34.9% | -69.1% | +359.9% | -32.7% | |
| – | +57.1% | -33.0% | -72.2% | -51.7% | +1,437.6% | +32.9% | -4.0% | +34.1% | +18.4% | -48.2% | +210.6% | -50.2% | +38.3% | -54.7% | +284.7% | +77.9% | +74.1% | -35.7% | +21.6% | -36.3% | +10.2% | +359.8% | -2.5% | -37.0% | -42.6% | -35.2% | -37.8% | |
| – | +40.1% | -19.4% | +4.1% | -92.0% | +131.5% | +142.4% | -33.0% | +14.7% | +249.6% | -41.1% | -52.6% | -67.0% | +382.0% | +71.2% | +280.9% | -15.1% | +161.5% | +126.0% | -60.8% | -37.5% | -49.9% | +838.1% | -57.9% | +46.1% | -79.5% | -50.1% | -100.0% | |
| – | -12.6% | +23.7% | +12.1% | -72.9% | – | – | – | – | – | – | – | – | – | – | -1.4% | +454.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -10.9% | -28.3% | -54.5% | -40.3% | -11.9% | +142.6% | +4.0% | +2.8% | -11.9% | -3.1% | -19.2% | +6.8% | +22.7% | +695.1% | +58.8% | +59.4% | +23.5% | +103.0% | -12.9% | -19.9% | -11.2% | +53.8% | -55.7% | – | – | – | |
| – | – | – | – | – | – | – | – | +0.0% | -9.1% | +0.0% | +159.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +4.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | |
| – | +35.0% | +0.0% | +74.1% | +3.2% | -7.1% | +4.6% | +154.2% | +11.2% | -7.2% | +63.8% | +28.0% | -13.8% | -16.7% | -19.6% | -23.6% | -16.5% | -18.2% | +95.3% | -21.2% | -20.8% | -22.4% | -14.8% | -16.5% | -18.9% | – | – | – | |
| – | +45.4% | -26.8% | +4.7% | +1.4% | -30.3% | +357.3% | +2.0% | +126.0% | -29.8% | +127.5% | -2.2% | -53.9% | +47.7% | -22.4% | +244.2% | -42.8% | +87.2% | +32.8% | -11.1% | -1.5% | +214.3% | -43.2% | +22.4% | +31.1% | -57.5% | -16.6% | +12.4% | |
| – | +50.4% | -28.2% | +6.1% | +3.3% | -30.1% | +366.2% | -23.4% | +65.9% | -51.1% | +338.5% | +31.5% | -66.7% | +71.6% | -24.1% | +245.8% | -51.4% | +123.4% | +39.3% | -19.2% | -0.3% | -9.4% | +30.4% | +57.6% | +47.3% | -56.1% | -17.0% | +23.6% | |
| – | – | +29.8% | -60.1% | -24.9% | +1,504.3% | +826.0% | – | – | – | – | +0.0% | – | – | -12.3% | +34.5% | +27.1% | +84.0% | +74.3% | +23.0% | – | – | +12.3% | +11.8% | +7.7% | +583.9% | -87.0% | +13.0% | |
| – | +27.4% | -21.9% | +5.0% | -29.4% | -19.9% | +160.4% | -13.5% | +7.8% | -10.1% | -79.1% | +315.6% | -0.3% | -25.8% | -10.4% | +129.6% | -14.9% | +119.4% | +56.9% | +21.4% | +29.8% | -30.6% | -80.8% | +1,804.9% | -24.6% | -78.0% | +38.6% | -59.3% | |
| – | – | -24.6% | -57.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -75.8% | -19.8% | +11.1% | – | – | – | |
| – | +42.5% | -16.4% | -49.8% | -24.9% | +303.9% | +3.3% | +50.9% | -22.7% | +71.0% | -38.4% | +217.0% | -23.2% | +1.7% | -27.4% | +52.7% | +112.0% | +58.0% | -29.8% | +15.5% | -38.9% | -96.0% | +13,324.4% | -13.3% | -44.4% | -47.2% | -41.6% | -64.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +11.4% | +22.4% | +46.8% | +31.2% | +32.3% | +7.9% | +65.8% | +31.7% | +5.8% | +70.1% | +38.1% | +22.3% | +8.1% | +35.0% | +28.9% | +15.1% | +7.1% | +11.9% | +13.0% | +34.7% | +36.3% | +26.3% | -90.7% | +11.5% | +22.5% | +72.6% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.